Eli Lilly Breaks Ground On $3.5B Manufacturing Facility In Pennsylvania's Lehigh Valley; Site To Create 850 High-Wage Jobs And 2,000 Construction Jobs
Benzinga Newsdesk 1 day ago
News
Facility will manufacture injectable medicines, including retatrutideSite will create 850 high-wage jobs and 2,000 construction jobsINDIANAPOLIS, Nov. 12, 2026 /PRNewswire/ -- Eli Lilly and Company (NYSE:LLY) today
Facility will manufacture injectable medicines, including retatrutide
Site will create 850 high-wage jobs and 2,000 construction jobs
INDIANAPOLIS, Nov. 12, 2026 /PRNewswire/ -- Eli Lilly and Company (NYSE:LLY) today broke ground on a $3.5 billion manufacturing facility in Pennsylvania's Lehigh Valley. The site is one of 10 new U.S. manufacturing sites announced since 2020 and one of four among them dedicated to injectable medicines and devices. Part of the company's $50 billion push to expand medicine production in the U.S., the Lehigh Valley site will add capacity for the next generation of obesity treatments, including retatrutide, a first-in-class investigational GIP, GLP-1 and glucagon triple hormone receptor agonist.